Abalone Bio
About:
Abalone Bio develops full-spectrum antibody drugs to access promising therapeutic targets and unlock new disease treatments.
Website: https://www.abalonebio.com/
Top Investors: National Science Foundation, Y Combinator, Pioneer Fund, Asymmetry Ventures, Harmonix Fund
Description:
Total Funding Amount:
$1.47M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Richmond, California, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)abalonebio.com
Founders:
Gustavo Pesce, Richard Yu
Number of Employees:
11-50
Last Funding Date:
2022-01-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai